
SINOTHERAPEUTICS INC. — Investor Relations & Filings
Sinotherapeutics Inc. is a pharmaceutical company specializing in the research, development, and commercialization of complex generic drugs and innovative drug delivery systems. The company focuses on high-barrier formulations, particularly oral solid dosage forms with modified-release or controlled-release profiles. Utilizing advanced technology platforms, Sinotherapeutics develops products designed to improve patient compliance and therapeutic outcomes. Its operations encompass the full lifecycle of drug development, from formulation design and clinical evaluation to large-scale manufacturing under global quality standards. The company maintains a robust pipeline targeting various therapeutic areas, including cardiovascular diseases, central nervous system disorders, and metabolic conditions. Sinotherapeutics aims to provide high-quality, affordable medications by leveraging its expertise in complex chemistry and pharmaceutical engineering.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度环境、社会和公司治理报告摘要 | 2026-04-29 | Chinese | |
| 董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-04-29 | Chinese | |
| 第二届董事会第二十六次会议决议公告 | 2026-04-29 | Chinese | |
| 国泰海通证券股份有限公司关于上海宣泰医药科技股份有限公司2025年度募集资金存放与使用情况的专项核查意见 | 2026-04-29 | Chinese | |
| 2025年度内部控制评价报告 | 2026-04-29 | Chinese | |
| 董事会审计委员会2025年度履职情况报告 | 2026-04-29 | Chinese |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39409946 | 2025年度环境、社会和公司治理报告摘要 | 2026-04-29 | Chinese | ||
| 39409943 | 董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-04-29 | Chinese | ||
| 39409940 | 第二届董事会第二十六次会议决议公告 | 2026-04-29 | Chinese | ||
| 39409933 | 国泰海通证券股份有限公司关于上海宣泰医药科技股份有限公司2025年度募集资金存放与使用情况的专项核查意见 | 2026-04-29 | Chinese | ||
| 39409895 | 2025年度内部控制评价报告 | 2026-04-29 | Chinese | ||
| 39409890 | 董事会审计委员会2025年度履职情况报告 | 2026-04-29 | Chinese | ||
| 39409882 | 关于召开2025年年度股东会的通知 | 2026-04-29 | Chinese | ||
| 39409875 | 2025年年度报告摘要 | 2026-04-29 | Chinese | ||
| 39409872 | 关于会计师事务所2025年度履职情况评估报告 | 2026-04-29 | Chinese | ||
| 39409866 | 关联交易管理制度(2026年4月) | 2026-04-29 | Chinese | ||
| 39409862 | 关于2025年度利润分配方案的公告 | 2026-04-29 | Chinese | ||
| 39409860 | 独立董事候选人声明与承诺(王有平) | 2026-04-29 | Chinese | ||
| 39409855 | 2026年度“提质增效重回报”行动方案 | 2026-04-29 | Chinese | ||
| 39409852 | 上会会计师事务所(特殊普通合伙)关于上海宣泰医药科技股份有限公司2025年度募集资金存放、管理与实际使用情况的鉴证报告 | 2026-04-29 | Chinese | ||
| 39409834 | 2025年度审计报告 | 2026-04-29 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
SINOTHERAPEUTICS INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58270/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58270 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58270 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58270 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58270}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SINOTHERAPEUTICS INC. (id: 58270)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.